ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 126 • 2023 Pediatric Rheumatology Symposium

    Facilitating Peer-to-Peer Conversations Around Key Clinical Trial Recruitment Barriers in the Limit-JIA Trial Using Low-Fidelity Video Capture

    Melanie Kohlheim1, Eveline Wu2, Laura Schanberg3, Vincent Del Gaizo1, Catherine Lavallee4, Marc Natter5, Katie Clem6, Brian Shakley6 and Kevin Urban7, 1CARRA, Washington, DC, 2UNC Chapel Hill, Chapel Hill, NC, 3Duke University Medical Center, Durham, NC, 4Virginia Tech Carilion School of Medicine, ROANOKE, VA, 5Boston Children's Hospital, Boston, MA, 6LIFT 1428, Llc, Ooltewah, TN, 7Business Coaching for Creatives, New York, NY

    Background/Purpose: The LIMIT-JIA trial aims to study if early abatacept treatment can prevent disease extension in children with recent-onset, uncomplicated, and oligoarticular or limited JIA.…
  • Abstract Number: 133 • 2023 Pediatric Rheumatology Symposium

    An Interdisciplinary Team Approach to Implementation of a Social Determinants of Health Screener for Pediatric Rheumatology Patients

    Sarah Campbell1, Rosemary Peterson2, Sarah Barrientos3, Elinore Benett3 and Cori Christenholz3, 1University of Texas at Austin Dell Medical School, Austin, TX, 2Dell Medical School at UT Austin, Austin, TX, 3Dell Children's Medical Center Department of Rheumatology, Austin, TX

    Background/Purpose: Adolescents with chronic disease often struggle with the transition from pediatric to adult healthcare leading to poor follow-up and negative health outcomes. Social determinants…
  • Abstract Number: 131 • 2023 Pediatric Rheumatology Symposium

    Improving Methotrexate Documentation in Electronic Health Records – a Quality Improvement Initiative

    Jayne MacMahon1, Jeanine McColl2, Alaa Al-Shehab1, Deborah Levy3, Ronald laxer1 and Shirley Tse1, 1University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada, 2University of Alberta, Edmonton, AB, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Prescribing methotrexate,is common practice in rheumatology. Appropriate medication counselling and documentation is important. In our province, as per thephysician regulatory body the College of…
  • Abstract Number: 101 • 2023 Pediatric Rheumatology Symposium

    Differences in Clinical and Patient-reported Outcomes in Juvenile Dermatomyositis by Race and Ethnicity

    Susan Kim1, Rebecca Olveda2 and Jessica Neely2, 1UCSF Benioff Children's Hospital, San Francisco, CA, 2UCSF, San Francisco, CA

    Background/Purpose: Previous studies in juvenile dermatomyositis (JDM) have shown that patients from minoritized ethnicities and those with lower family income are more likely to have…
  • Abstract Number: 120 • 2023 Pediatric Rheumatology Symposium

    The Brazilian Registry of Juvenile Dermatomyositis (JDM): I- Onset Clinical Features and Disease Activity Scores by DAS-20 over 2-Years-Follow Up

    Beatriz Carneiro1, Adriana Elias1, Teresa Robazzi2, Ana Julia Moraes3, Sheila Oliveira4, Flavio Sztajnbok5, Luciana Carvalho6, Luciana Marques7, Silvana Sacchetti8, Maria Teresa Terreri9, Simone Appenzelle10, Roberto Marini11, Andre Cavalcante12, Marcia Bandeira13, Cristina Magalhaes14, Melissa Fraga15, Iloite Scheibel16, Isabela Daud1, Darcisio Antonio17, Claudio Len18, Clovis Silva19, Taciana Fernandes17 and Claudia Magalhaes20, 1Instituto da Criança - Universidade de São Paulo (USP), São Paulo, Brazil, 2Universidade Federal da Bahia, Brazil, 3Universidade Federal do Para, Brazil, 4Universidade Federal do Rio de janeiro, Rio de Janeiro, 5Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil, 6Universidade de Sao Paulo- Ribeirao Preto, São Paulo, Brazil, 7Hospital Albert Sabin, Brazil, 8Santa Casa de Sao Paulo, Brazil, 9UNIFESP, São Paulo, Brazil, 10University of Campinas, Campinas, Sao Paulo, Brazil, 11UNICAMP, São Paulo, Brazil, 12Hospital Materno-Infantil de Goiania, Brazil, 13Hospital Pequeno Principe- Curitiba, Brazil, 14Hospital Jose de Alencar - Brasilia, Brazil, 15Hospital Darcy Vargas, Brazil, 16Hospital Conceição de Porto Alegre, Brazil, 17Universidade Estadual Paulista (UNESP) Botucatu, Brazil, 18Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 19Universidade de São Paulo, São Paulo, Brazil, 20São Paulo State University, Pediatric Rheumatology Division, Botucatu, Brazil

    Background/Purpose: A national registry was set up, enrolling new onset JDM cases in 18 hospitals, during 3-years (2015-2018) with 2-years follow up, in a low…
  • Abstract Number: 127 • 2023 Pediatric Rheumatology Symposium

    What’s in a Name? A20 Protein Expression in an in Vitro Model of A20 Haploinsufficiency

    Patricia Pontes Aires1, DANIELA GERENT PETRY PIOTTO1, Andre Cunha1, Sandro Perazzio2 and Maria Teresa Terreri3, 1Universidade Federal de São Paulo, São Paulo, Brazil, 2Universidade de So Paulo; Fleury Laboratories, São Paulo, Brazil, 3UNIFESP, São Paulo, Brazil

    Background/Purpose: Tumor necrosis factor alpha (TNF-alpha) induced protein 3 gene, or TNFAIP3, encodes the A20 protein, an important regulator of the NF-κB pathway. Since its…
  • Abstract Number: 123 • 2023 Pediatric Rheumatology Symposium

    Development of Specific Classification Criteria for Juvenile System Sclerosis Patients: A Scoping Review

    Ioana Dobre1, Suzanne Li2, Natalia Vasquez Canizares3, Barbara Reich4, Xurong Zhao5, Quinn McCormick6 and Marinka Twilt5, 1Alberta Children's Hospital/University of Calgary, Calgary, AB, Canada, 2Hackensack Meridian School of Medicine, Joseph M. Sanzari Children's Hospital, Hackensack, NJ, 3Children's Hospital at Montefiore, New York, NY, 4Hackensack University Medical Center, Hackensack, NJ, 5Alberta Children's Hospital, Calgary, AB, Canada, 6Hackensack Medical Hospital Network, Hackensack, NJ

    Background/Purpose: Juvenile systemic sclerosis (jSSc) is associated with one of the highest morbidity and mortality rate in pediatric rheumatology, yet care recommendations are based upon…
  • Abstract Number: 136 • 2023 Pediatric Rheumatology Symposium

    Incidence and Disease Burden of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis After Non-Pharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea

    Je Hee Shin1, Jung Yoon Pyo2, Minkyung Han3, Myeongjee Lee3, Sung Min Lim1, Jee Yeon Baek1, Ji Young Lee1, Ji-Man Kang1, InKyung Jung3 and Jong Gyun Ahn1, 1Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea, 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, 3Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea

    Background/Purpose: Several countries have implemented non-pharmaceutical interventions (NPIs) against the coronavirus disease 2019 (COVID-19) pandemic. We investigated the impact of NPIs on the incidence of…
  • Abstract Number: 137 • 2023 Pediatric Rheumatology Symposium

    Geographic Mapping of Adolescents with Rheumatic Disease: Racial and Ethnic Diversity by Texas County

    Kristina Ciaglia1, Chan-hee Jo2, Yuhan Ma2, Tracey Wright3 and Lorien Nassi1, 1University of Texas Southwestern, Dallas, TX, 2Scottish Rite Hospital for Children, Dallas, TX, 3University of Texas Southwestern, Scottish Rite Hospital for Children, Dallas, TX

    Background/Purpose: Rheumatic disease disproportionately impacts specific racial and ethnic groups frequently, resulting in health care inequities. Health care disparities are prevalent within certain geographic areas…
  • Abstract Number: 122 • 2023 Pediatric Rheumatology Symposium

    Juvenile Arthritis in Minnesota: Geospatial Variability and Environmental Exposures in Juvenile Idiopathic Arthritis

    Colleen Correll1, Austin Rau2 and Jesse Berman2, 1University of Minnesota, Minneapolis, MN, 2University of Minnesota, Minneapolis

    Background/Purpose: It is widely accepted that juvenile idiopathic arthritis (JIA) is caused by a combination of genetic and environmental factors, but the potential environmental triggers…
  • Abstract Number: 091 • 2023 Pediatric Rheumatology Symposium

    Achieving Remission in Childhood-onset Systemic Lupus Erythematosus: Rapid Implementation of an EMR-integrated Dashboard to Measure Disease Activity and Remission Rates

    Kaleo Ede1, Nikita Goswami2, Elisa Wershba2, Michael Shishov2, Samantha Casselman2, Pierina Ortiz2 and Vinay Vaidya2, 1Phoenix Children's Hosptial; University of Arizona College of Medicine- Phoenix, Phoenix, AZ, 2Phoenix Children's Hospital, Phoenix, AZ

    Background/Purpose: Children with childhood-onset systemic lupus erythematosus (cSLE) experience more severe disease than their adult counterparts, in addition to high rates of clinical depressive symptoms…
  • Abstract Number: 128 • 2023 Pediatric Rheumatology Symposium

    Multisystem Inflammatory Syndrome in Children and Systemic Juvenile Idiopathic Arthritis Share Clinical Phenotypes and Genetic Contributions

    Paul Tsoukas1, Hua Lu2, Marla Mendes de Aquino2, Michael Ombrello3, Lisa Strug2 and Rae Yeung4, 1The Hospital of Sick Children, Department of Paediatrics, University of Toronto, Division of Rheumatology; Cell Biology Program, The Hospital for Sick Children Research Institute, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada, 3Translational Genetics and Genomics Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, North Bethesda, MD, 4The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Multisystem inflammatory syndrome in children (MIS-C) is a novel clinical entity presenting following SARS CoV2 infection. This study describes a subgroup of MIS-C patients…
  • Abstract Number: 081 • 2023 Pediatric Rheumatology Symposium

    Predicting Extension in Juvenile Idiopathic Arthritis

    Megan Simonds1, Kathleen Sullivan2 and AnneMarie Brescia1, 1Nemours Children's Health, Wilmington, DE, 2Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood and carries a risk of permanent joint damage and disability [1]. In…
  • Abstract Number: 090 • 2023 Pediatric Rheumatology Symposium

    Safety Outcomes of Combined Biologics Use in Pediatric Rheumatology: A Single Center Experience

    Angela Chun1, MaiLan Nguyen1, Marietta De Guzman2 and Andrea Ramirez3, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Baylor College of Medicine, Houston, TX

    Background/Purpose: The management of pediatric rheumatic disease has been forever changed by the advent of biologic drugs and the pursuit of targeted therapy. There is…
  • Abstract Number: 096 • 2023 Pediatric Rheumatology Symposium

    DADA2 – a Case Series from North India

    Manjari Agarwal, Jyotsna verma, ratna puri and Sujata Sawhney, Sir Ganga Ram Hospital, New Delhi, India

    Background/Purpose: We present a series of children previously diagnosed and managed as Polyarteritis nodosa at our unit. Due to ease of availability of mutation analysis…
  • « Previous Page
  • 1
  • …
  • 361
  • 362
  • 363
  • 364
  • 365
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology